BIABooster: Online DNA Concentration and Size Profiling with a Limit of Detection of 10 fg/μL and Application to High-Sensitivity Characterization of Circulating Cell-Free DNA

被引:32
作者
Andriamanampisoa, Comtet-Louis [1 ]
Bancaud, Aurelien [2 ]
Boutonnet-Rodat, Audrey [1 ]
Didelot, Audrey [3 ]
Fabre, Jacques [1 ]
Fina, Frederic [4 ,5 ,6 ]
Garlan, Fanny [3 ]
Garrigou, Sonia [3 ]
Gaudy, Caroline [7 ]
Ginot, Frederic [1 ]
Henaff, Daniel [5 ]
Laurent-Puig, Pierre [3 ,8 ]
Morin, Arnaud [1 ]
Picot, Vincent [1 ]
Saias, Laure [1 ]
Taly, Valerie [3 ]
Tomasini, Pascale [9 ]
Zaanan, Aziz [3 ,8 ]
机构
[1] Picometr Technol, 478 Rue Decouverte, F-31670 Labege, France
[2] Univ Toulouse, CNRS, LAAS CNRS, 7 Ave Colonel Roche, F-31400 Toulouse, France
[3] Paris Descartes Univ, CNRS SNC5014, INSERM UMR S1147, 45 Rue St Peres, Paris, France
[4] Timone, AP HM, Lab Biol Med, Unite Dev Technol, F-13005 Marseille, France
[5] ID Solut, 310 Rue Louis Pasteur, F-34790 Grabels, France
[6] Timone II, AP HM, Serv Anat Pathol & Neuropathol, F-13005 Marseille, France
[7] Timone, AP HM, Serv Dermatol Venereol & Cancerol Cutanee, F-13005 Marseille, France
[8] Hop Europeen Georges Pompidou, AP HP, Dept Digest Oncol, 20 Rue Leblanc, F-75015 Paris, France
[9] Aix Marseille Univ, Hop Nord, AP HM, Multidisciplinary Oncol & Therapeut Innovat Dept, F-13015 Marseille, France
关键词
COLORECTAL-CANCER; TUMOR-DNA; INTEGRITY; PLASMA; MARKER; CFDNA;
D O I
10.1021/acs.analchem.7b04034
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
We describe a technology to perform sizing and concentration analysis of double stranded DNA with a sensitivity of 10 fg/mu L in an operating time of 20 min. The technology is operated automatically on a commercial capillary electrophoresis instrument using electro-hydrodynamic actuation. It relies on a new capillary device that achieves online concentration of DNA at the junction between two capillaries of different diameters, thanks to viscoelastic lift forces. Using a set of DNA ladders in the range of 100-1500 bp, we report a sizing accuracy and precision better than 3% and a concentration quantification precision of similar to 20 When the technology is applied to the analysis of clinical samples of circulating cell-free DNA (cfDNA), the measured cfDNA concentrations are in good correlation with those measured by digital PCR Furthermore, the cfDNA size profiles indicate that the fraction of low molecular weight cfDNA in the range of 75-240 bp is a candidate biomarker to discriminate between healthy subjects and cancer patients. We conclude that our technology is efficient in analyzing highly diluted DNA samples and suggest that it will be helpful in translational and clinical research involving cfDNA.
引用
收藏
页码:3766 / 3774
页数:9
相关论文
共 28 条
[1]   Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index [J].
Beffagna, Giorgia ;
Sammarco, Alessandro ;
Bedin, Chiara ;
Romualdi, Chiara ;
Mainenti, Marta ;
Mollo, Antonio ;
Cavicchioli, Laura ;
Ferro, Silvia ;
Trez, Davide ;
De Maria, Raffaella ;
Nitti, Donato ;
Saccani, Andrea ;
Campanella, Michelangelo ;
Agostini, Marco ;
Zappulli, Valentina .
PLOS ONE, 2017, 12 (01)
[2]  
Bruin GJM, 2000, ELECTROPHORESIS, V21, P3931, DOI 10.1002/1522-2683(200012)21:18<3931::AID-ELPS3931>3.0.CO
[3]  
2-M
[4]   Quantitative Analysis in Capillary Electrophoresis: Transformation of Raw Electropherograms into Continuous Distributions [J].
Chamieh, Joseph ;
Martin, Michel ;
Cottet, Herve .
ANALYTICAL CHEMISTRY, 2015, 87 (02) :1050-1057
[5]   Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification [J].
Devonshire, Alison S. ;
Whale, Alexandra S. ;
Gutteridge, Alice ;
Jones, Gerwyn ;
Cowen, Simon ;
Foy, Carole A. ;
Huggett, Jim F. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2014, 406 (26) :6499-6512
[6]   Gefitinib Treatment in EGFR Mutated Caucasian NSCLC Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status [J].
Douillard, Jean-Yves ;
Ostoros, Gyula ;
Cobo, Manuel ;
Ciuleanu, Tudor ;
Cole, Rebecca ;
McWalter, Gael ;
Walker, Jill ;
Dearden, Simon ;
Webster, Alan ;
Milenkova, Tsveta ;
McCormack, Rose .
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) :1345-1353
[7]   Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care [J].
El Messaoudi, Safia ;
Mouliere, Florent ;
Du Manoir, Stanislas ;
Bascoul-Mollevi, Caroline ;
Gillet, Brigitte ;
Nouaille, Michelle ;
Fiess, Catherine ;
Crapez, Evelyne ;
Bibeau, Frederic ;
Theillet, Charles ;
Mazard, Thibault ;
Pezet, Denis ;
Mathonnet, Muriel ;
Ychou, Marc ;
Thierry, Alain R. .
CLINICAL CANCER RESEARCH, 2016, 22 (12) :3067-3077
[8]   Circulating cell free DNA: Preanalytical considerations [J].
El Messaoudi, Safia ;
Rolet, Fanny ;
Mouliere, Florent ;
Thierry, Alain R. .
CLINICA CHIMICA ACTA, 2013, 424 :222-230
[9]   Monitoring tumor-derived cell-free DNA in patients with solid tumors: Clinical perspectives and research opportunities [J].
Esposito, Angela ;
Bardelli, Alberto ;
Criscitiello, Carmen ;
Colombo, Nicoletta ;
Gelao, Lucia ;
Fumagalli, Luca ;
Minchella, Ida ;
Locatelli, Marzia ;
Goldhirsch, Aron ;
Curigliano, Giuseppe .
CANCER TREATMENT REVIEWS, 2014, 40 (05) :648-655
[10]   Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study) [J].
Garlan, Fanny ;
Laurent-Puig, Pierre ;
Sefrioui, David ;
Siauve, Nathalie ;
Didelot, Audrey ;
Sarafan-Vasseur, Nasrin ;
Michel, Pierre ;
Perkins, Geraldine ;
Mulot, Claire ;
Blons, Helene ;
Taieb, Julien ;
Di Fiore, Frederic ;
Taly, Valerie ;
Zaanan, Aziz .
CLINICAL CANCER RESEARCH, 2017, 23 (18) :5416-5425